EXPE vs RPTX · P/E 20, rev $7.74B vs $61.8M cap
Expedia Group Inc. (EXPE) versus Repare Therapeutics Inc (RPTX) — a side-by-side from cached financials, not a winner call.
Expedia Group Inc. (EXPE) is a travel services company listed on US.
Repare Therapeutics Inc (RPTX) is a biotechnology company listed on US.
Latest reported EXPE revenue for 2026-06-30 was $7.74B. Net income was $872.0M. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
RPTX does not have a complete income-statement cache yet.
EXPE currently screens at market cap $21.71B and trailing P/E 20.4. RPTX currently screens at market cap $61.8M.
Not investment advice. Open the EXPE and RPTX stock pages for the full models.
Not investment advice.